News

10/23/2011Meet Sovicell at AAPS in Washington DC at joint booth with ADMEcell10/17/2011Sovicell will present a poster on “TRANSIL High Sensitivity Binding Assay: 9/20/2011Sovicell will be attending Agilent Technologies’ Automation User Group Meeting in San Francisco, California, which is being held from September 20th to 22nd. 9/19/2011Sovicell will be attending the 2nd World Conference on Physico-Chemical Methods in Drug Discovery and Development in Zadar, Croatia, which is being held from September 19th to 22nd.

Contract Research Services

Intestinal Absorption Assay Service

Our dedicated team of scientists will carry out the TRANSIL Intestinal Absorption Assay in our labs using your drug candidates or other test substances to assess their ability to cross the intestinal epithelium membrane. Since most drugs passively enter the bloodstream through the small intestine’s epithelium, uptake/absorption of a drug by this tissue critically affects its bioavailability and peak bloodstream concentrations.

The assay evaluates the membrane affinity of a drug candidate, which is directly related to permeation, and thereby assesses its ability to cross the intestinal epithelium, providing a measurement of the intestinal absorption of a drug. In conjuction with our solubility assay it is possible to predict the percentage of an oral dose absorbed via the intestine.

To find out further information or to receive advice about your specific needs, please contact our dedicated contract research team: service@sovicell.com.

The Sovicell service advantage:

tailor made services; customized to our customers’ needs
responsive, timely and professional delivery of results including presentation & interpretation
state-of-the-art technology, methods and equipment
experienced and knowledgeable staff

To find out further information or to receive advice about your specific needs, please contact our dedicated contract research team: service@sovicell.com.